Janssen Research & Development, Llc

This study tested whether adding the drug aticaprant to standard antidepressants could prevent depression from returning in people with major depressive disorder who also experience a loss of interest or pleasure (anhedonia). The trial was stopped early and included 47 participan…

This study tested an experimental drug called JNJ-63733657, designed to target tau protein tangles in the brain, in people with early Alzheimer's disease. The goal was to see if it could slow down memory and thinking decline compared to a placebo. The trial was stopped early (ter…